openPR Logo
Press release

Third Annual Fighting Leukemia with Fashion Event Dedicates an Exciting Evening to a Worthy Cause

06-06-2011 06:29 AM CET | Fashion, Lifestyle, Trends

Press release from: Beautiful Planning Marketing & PR

City Model and Talent and the Leukemia & Lymphoma Society Present Charity Fundraiser Fashion Show on June 23rd 2011

New York, New York (May 31, 2011) – City Model and Talent, today announced the date for their much-anticipated third annual “Fighting Leukemia with Fashion” event to benefit The Leukemia & Lymphoma Society (LLS) and to add potential donors to the bone marrow registry. The event will take place on the evening of June 23rd 2011 404NYC located at 404 10th Avenue and West 33rd Street. Doors will open for the evening at 7:00PM, with the main fashion event beginning promptly at 8:30PM. The event also offers an open bar from 7:00PM to 9:00PM sponsored by Diageo Liquors, features a performance by Damien Richards & The D. Rich Project, and provides an opportunity for guests to participate in the bone marrow drive.

Proceeds from the evening will benefit LLS, the world’s largest voluntary health organization dedicated to increasing funds for lifesaving blood cancer research and providing free information and support services to those touched by cancer. Funds from “Fighting Leukemia with Fashion” will help advance LLS’s mission to cure leukemia, lymphoma, Hodgkin’s disease, myeloma, and improve the quality of life of patients and their families.

“Our Fighting Leukemia with Fashion event has grown year to year and that is truly exciting,” states Jaqueline Krentzel-Miller, CEO of City Model and Talent. “Fashion is something that we live and breathe every day. However we have the option of changing our outfits and changing our style. The goal of this event is to bring that same hope to people living with Leukemia. With everyone’s help, we can change their future and change the outcome of how the disease affects their lives.”

Up and coming designers being featured at this years exclusive event include Kahri by KahriAnne Kerr, Ingrid Thelisme, and Brazilian Bezel Swimwear. Sponsors have also been formally announced as Restaurant Lounge 404, Society Ties, The Leukemia & Lymphoma Society’s Young Professionals Volunteer Group, top NYC PR Firm Beautiful Planning Marketing & PR, Diageo, VLounge Video, Johnny Walker Black, Ketel One, Tanqueray, Jose Cuervo, Captain Morgan, Baileys Irish Cream, and DKMS. DKMS is an organization that is dedicating to saving lives by recruiting bone marrow donors for leukemia patients. DKMS is the largest bone marrow donor center in the world, and has worked with “Fighting Leukemia with Fashion” in the past and has had much success in finding bone marrow donors through the popular event.

Pre-sale tickets are currently available for $30 until June 8th. General admission tickets will be on sale for $35 until June 23rd. Tickets will also be available at the door for $40. For more information on the Fighting Leukemia with Fashion Event, City Model and Talent, or for media access, please call 877.841.7244 or email info@beautifulplanning.com.

About City Model & Talent

Established in 2002, City Model & Talent (CMT) is an innovative, dynamic, and professional organization dedicated to the promotion of models and talent (actors, singers & dancers) into the fashion and entertainment industry. Essentially, CMT is a scouting and development company designed to assist clients with entry into this industry. CMT is recognized as a leading force in marketing and casting their clients for commercials, print work, music videos, and movies as promotional model/spokespeople. Our professional staff is committed to develop, market, cast, and manage your talents to the best of their ability. CMT is the creator of the Fighting Leukemia With Fashion, and continues to oversee the projects growth year after year.

Beautiful Planning Marketing & PR
12 Desbrosses Street
New York, NY 10013

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Third Annual Fighting Leukemia with Fashion Event Dedicates an Exciting Evening to a Worthy Cause here

News-ID: 177821 • Views:

More Releases for Leukemia

Pipeline Review, H2 2017 of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic …
"Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2017" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. . . Description- '
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, T …
Orbisreserach.Com Adds “H1 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Market Pipeline Review 2017 Trend Analysis Report Report” To Its Research Database Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2017, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) pipeline landscape. Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in the blood-forming cells of the
Acute Lymphoblastic Leukemia (ALL) Market grows with high incidence of acute lym …
Acute lymphoblastic leukemia (ALL) is a cancer of white blood cells called as lymphocytes in bone marrow. It is a malignant disease in which early precursor lymphoid cells proliferate and replace the normal hematopoietic cells of bone marrow. ALL is the most common type of cancer in children. There is overproduction of lymphoblasts in the bone marrow when a person suffers from ALL that continuously multiply, damaging the bone marrow
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical T …
ReportsWorldwide has announced the addition of a new report title Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical trials scenario. This report provides top line data relating to
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Tri …
ReportsWorldwide has announced the addition of a new report title Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) clinical trials scenario. This report provides top line data relating to
H2 2016 Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Therapeut …
Albany, New York, January 03, 2017: A recent forecast report focusing on the Acute Myelocytic Leukemia Market has been added to the wide portfolio of Market Research Hub (MRH). It is entitled as, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016” which has been equipped by in-depth market examination with inputs from the industry experts. It covers the current market scenario and also its future growth